trial

Transcranial Magnetic Stimulation for the Treatment of Auditory Hallucinations in Schizophrenia

NCTId NCT01595503
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Terminated
Enrollment 5 (actual)
Sponsored by University of Michigan
Primary completion 2012-08
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Terminated
Enrollment
5 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2011-05
Primary completion
2012-08
Eligibility
ALL · 18 Years · 60 Years

Interventions & indications

Drugs
rTMS with fMRI-based targetingrTMS with landmark-based targeting

Sponsors

University of MichiganLead Sponsor

Investigators

1
Stephan F Taylor, M.D.Principal Investigator

Sites

1 total
Ann Arbor, United States

Facts & assertions

4 sourced
Enrollment
5
Phase
NA
Primary Completion Date
2012-08
Status
TERMINATED
relationships
The graph out of here
drug
rTMS with fMRI-based targeting
drug
rTMS with landmark-based targeting
drug
lead_sponsor
University of Michigan
company
indication
Schizophrenia
indication
Hallucinations
indication
Schizophrenia
indication
investigator
Stephan F Taylor, M.D.
person